Gardiner has served as medical director, global medical affairs & senior medical officer for Bristol-Myers Squibb (BMS) Medical Imaging and vice president, medical sciences for the medical imaging division. Prior to joining BMS, Peter served as vice president, medical affairs for DuPont’s Medical Imaging business. Peter has held clinical research and medical affairs positions of increasing responsibility with Gensia, Inc and GD Searle & Co in both the USA and the UK. After gaining his medical degree from Leeds University in the UK, Peter trained in internal medicine and cardiology. Peter is a member of the Royal College of Physicians, UK, and of the Faculty of Pharmaceutical Medicine.

“We are very pleased to have Dr. Gardiner join our team as we begin to pursue clinical applications for the diagnostic product candidates we have currently, and continue to discover through our many collaborations,” said BG Medicine president and CEO Pieter Muntendam. “Dr. Gardiner’s extensive experience and knowledge in the field of cardiology, cardiovascular medical imaging and therapeutics will be a significant asset.”